- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01064778
Glycemic Index and Brain Function
The Effects of Dietary Glycemic Index on Brain Function
Descripción general del estudio
Descripción detallada
Most individuals have great difficulty following reduced calorie diets because they experience increased hunger. This process is regulated by specific brain areas. Though many psychological and environmental factors are involved, physiological effects of diet may have a significant impact. The postprandial rise in blood glucose, quantified by the glycemic index (GI), is of particular interest. High GI meals elicit hormonal events that limit availability of metabolic fuels, causing hunger and overeating, especially in people with high insulin secretion.
Our aim is to examine how postprandial changes after high versus low GI meals affect hunger and brain function in areas of intake control. Specifically, we speculate that obese individuals will demonstrate functional changes in brain areas of intake control and increased hunger after a high versus low GI meal.
We will recruit obese, young adults and quantify their insulin secretion during a 2-hour oral glucose tolerance test. A brief practice MRI session will serve to familiarize the subjects with the scanning process. During the two test sessions, standardized test meals with high versus low GI will be given in a randomized, blinded cross-over design. Serial blood levels of hormones, metabolic fuels, and metabolites will be correlated with perceived hunger, and a perfusion MRI scan will be performed to assess brain activation during the late postprandial phase, at the nadir of blood sugar and insulin levels (4 hours postprandial).
This work will inform an integrated physiological model relating peripheral postprandial changes to brain function and hunger. In addition, findings may provide evidence of a novel diet-phenotype, in which baseline clinical characteristics can be used to predict which weight loss diet will work best for a specific individual. Metabolite profiling might shed light on the mechanisms linking diet composition to brain function, and provide feasible clinical markers of the identified phenotype to facilitate translation into practice.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Estados Unidos, 02115
- Children's Hospital Boston
-
Boston, Massachusetts, Estados Unidos, 02215
- Brigham and Women's Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion criteria
- Males age 18 to 35 years
- BMI less than or equal to 25 for age and gender
Exclusion criteria
- weight > 300 lbs
- largest body circumference > 144cm
- body shape incompatible with MRI scanner or equipment
- MRI exclusion criteria
- large fluctuations in body weight (5% over preceding 6 months, 2.5% during the study)
- known medical problems that may affect metabolism or hormones
- diabetes mellitus (fasting plasma glucose ≥126 mg/dL)
- other abnormal laboratory screening tests
- taking any medications or dietary supplements that might affect body weight, appetite, or energy expenditure
- smoking or illicit substance abuse
- high levels of physical activity (>30 minutes per day, > 4days per week)
- currently following a weight loss diet
- allergies or intolerance to eggs, vanilla extract, equal, canola oil, milk, cornstarch, corn syrup
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Cuadruplicar
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Comparador activo: Low GI
|
Subjects will be instructed to consume a liquid test meal with a low GI over 5 minutes after baseline laboratory evaluations.
The low and high GI meal contain similar amounts of milk, oil, dried egg whites, equal, and vanilla extract.
The low GI meal corn-starch as a carbohydrate.
Both meals have similar macronutrient composition (60% carbohydrate, 15% protein, 25% fat), micronutrient profiles, physical properties, palatability and sweetness.
The high vs. low GI meals have a predicted difference in GI of 90 vs. 40, and consistent with this prediction, a pilot study in obese young adults found a 2.2-fold difference in glycemic response (p<0.001).
The test meals will provide 25% of individual daily energy requirements.
|
Experimental: High GI
|
Subjects will be instructed to consume a liquid test meal with a high GI over 5 minutes after baseline laboratory evaluations.
The low and high GI meal contain similar amounts of milk, oil, dried egg whites, equal, and vanilla extract.
The high GI meal contains corn-syrup as a carbohydrate.
Both meals have similar macronutrient composition (60% carbohydrate, 15% protein, 25% fat), micronutrient profiles, physical properties, palatability and sweetness.
The high vs. low GI meals have a predicted difference in GI of 90 vs. 40, and consistent with this prediction, a pilot study in obese young adults found a 2.2-fold difference in glycemic response (p<0.001).
The test meals will provide 25% of individual daily energy requirements.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
---|---|
Blood Flow in Brain Areas of Intake Control.
Periodo de tiempo: 4 hours postprandial
|
4 hours postprandial
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Subjective Hunger Rating
Periodo de tiempo: Every 30 minutes for 5 hours.
|
Every 30 minutes for 5 hours.
|
|
Blood Glucose Level
Periodo de tiempo: Every 30 minutes for 5 hours.
|
Every 30 minutes for 5 hours.
|
|
Blood Insulin Level
Periodo de tiempo: Every 30 minutes for 5 hours
|
Every 30 minutes for 5 hours
|
|
Blood Glucagon Level
Periodo de tiempo: Every 30 minutes for 5 hours.
|
Every 30 minutes for 5 hours.
|
|
Blood Growth Hormone Level
Periodo de tiempo: Every 30 minutes for 5 hours.
|
Every 30 minutes for 5 hours.
|
|
Blood Epinephrine Level
Periodo de tiempo: Every 30 minutes for 5 hours.
|
Every 30 minutes for 5 hours.
|
|
Blood Fatty Acids Level
Periodo de tiempo: Every 30 minutes for 5 hours.
|
measuring metabolite profiles
|
Every 30 minutes for 5 hours.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Belinda S Lennerz, MD, PhD, Boston Children's Hospital
- Investigador principal: David Alsop, PhD, Beth Israel Deaconess Medical Center
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- RA-003
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Low GI
-
University of MichiganNational Institute on Drug Abuse (NIDA); Brown University; Pennington Biomedical... y otros colaboradoresReclutamiento
-
GI DynamicsTerminadoObesidad | Diabetes tipo 2Brasil
-
National Institute of Diabetes and Digestive and...TerminadoObesidad | Pérdida de peso | Aumento de peso | Terapia de dieta | Terapia NutricionalEstados Unidos
-
Anumana, Inc.Mayo ClinicAún no reclutandoFracción de eyección ventricularEstados Unidos
-
DePuy InternationalTerminadoArtroplastia, Reemplazo, RodillaIrlanda
-
Centre hospitalier de l'Université de Montréal...Terminado
-
Radicle ScienceTerminadoDolor abdominal | Digestión | Trastornos gastrointestinalesEstados Unidos
-
TakedaTerminadoNorovirusFinlandia, Panamá, Colombia
-
Fondazione Policlinico Universitario Agostino Gemelli...DesconocidoMortalidad perioperatoriaItalia
-
Radicle ScienceReclutamientoDolor abdominal | Digestión | Trastornos gastrointestinalesEstados Unidos